drugset / Trial / NCT01388478
Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease
Phase 2
Completed
20 enrolled
Virginia Commonwealth University
Alzheimer's Drug Discovery Foundation · collabUniversity of Kansas · collab
NaSingle-groupOpen-labelTreatment
Summary
By doing this study, researchers will examine the safety and tolerability of R-pramipexole in participants with Alzheimer's disease. This study will also examine the body and brain's response to the study drug by measuring the amount of injury to the cells (oxidative stress) in the blood and spinal fluid and brain imaging before and after treatment.
Timeline
- Start
- 2011-07
- Primary completion
- 2014-01
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexpramipexole | Small molecule | 300 mg | — |